Same argument for TLD release. You don’t release TLD and then give the opposition the chance to distort it. Instead you release it with a comprehensive journal publication.
Hate to take this stance, but...
Why has the not been the case for every TLD release in the history of clinical trials?
History shows us that you do indeed release TLD and then give the opposition the chance to distort it...whatever the heck that means.
Can you provide one example of where a company released the first TLD for a drug or biologic and a publication at the same time? Maybe it has happened, just not aware of one.